153 related articles for article (PubMed ID: 34397191)
1. Immunohistochemistry Utilization in Medicare Beneficiaries by Mohs Surgeons From 2012-2017.
Patel P; Guzman AK; Tinklepaugh A; Ciocon D
J Drugs Dermatol; 2021 Aug; 20(8):905-906. PubMed ID: 34397191
[TBL] [Abstract][Full Text] [Related]
2. Trends in Medicare Billing Among Mohs Surgeons in the United States During 2012: A Retrospective Cohort Study.
Tsai S; Kooistra LJ; Conic RZ; Bordeaux JS
Dermatol Surg; 2019 Feb; 45(2):268-273. PubMed ID: 30199438
[TBL] [Abstract][Full Text] [Related]
3. MMS hotspots: a cross-sectional comparison of U.S. counties with and without Mohs micrographic surgery.
Sharma AN; Peterman N; Juhasz M; Shive M
Arch Dermatol Res; 2023 Dec; 316(1):21. PubMed ID: 38060044
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and comorbidities of Medicare beneficiaries receiving care from Mohs micrographic surgeons based on fellowship training and practice setting.
Gronbeck C; Feng H
Dermatol Online J; 2021 Aug; 27(8):. PubMed ID: 34755958
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Travel Distance and Time to In-Network Mohs Micrographic Surgeons Between Medicaid and Medicare Beneficiaries.
Beltrami EJ; Masison J; Gronbeck C; Feng H
Dermatol Surg; 2023 Feb; 49(2):200-201. PubMed ID: 36576969
[No Abstract] [Full Text] [Related]
6. The Current State of Mohs Surgery for the Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
Siscos SM; Neill BC; Seger EW; Hooton TA; Hocker TLH
Dermatol Surg; 2020 Oct; 46(10):1267-1271. PubMed ID: 32740213
[TBL] [Abstract][Full Text] [Related]
7. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.
Viola KV; Jhaveri MB; Soulos PR; Turner RB; Tolpinrud WL; Doshi D; Gross CP
Arch Dermatol; 2012 Apr; 148(4):473-7. PubMed ID: 22508870
[TBL] [Abstract][Full Text] [Related]
8. Practice Patterns for Mohs Surgeons of Varying Clinical Experience: A Cross-Sectional Analysis of a Medicare Claims Database.
Singh P; Smith FL; Brown MD
Dermatol Surg; 2022 Oct; 48(10):1029-1032. PubMed ID: 36095278
[TBL] [Abstract][Full Text] [Related]
9. Mohs Micrographic Surgery Volume and Payment Patterns Among Dermatologists in the Medicare Population, 2013.
Johnstone C; Joiner KA; Pierce J; Krouse RS
Am J Clin Oncol; 2018 Dec; 41(12):1199-1203. PubMed ID: 29672366
[TBL] [Abstract][Full Text] [Related]
10. Mohs micrographic surgery utilization in the Medicare population, 2009.
Donaldson MR; Coldiron BM
Dermatol Surg; 2012 Sep; 38(9):1427-34. PubMed ID: 22681892
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic utilization in Medicare beneficiaries receiving Mohs micrographic surgery.
Singh P; Mostaghimi A; Barbieri JS
J Am Acad Dermatol; 2020 Oct; 83(4):1184-1186. PubMed ID: 32068038
[No Abstract] [Full Text] [Related]
12. An ecological study of skin biopsies and skin cancer treatment procedures in the United States Medicare population, 2000 to 2015.
Wang DM; Morgan FC; Besaw RJ; Schmults CD
J Am Acad Dermatol; 2018 Jan; 78(1):47-53. PubMed ID: 28947293
[TBL] [Abstract][Full Text] [Related]
13. Use of physician assistants in Mohs micrographic surgery: a survey of fellowship-trained Mohs micrographic surgeons.
Hyde MA; Hadley ML; Roberson C; Jacobson A; Pappas L; Bowen GM
Dermatol Surg; 2010 Nov; 36(11):1700-3. PubMed ID: 20961351
[TBL] [Abstract][Full Text] [Related]
14. Association Between Surgeon-Specific Features and Number of Stages, Flaps, and Grafts in Mohs Micrographic Surgery: A Retrospective Observational Study of 59 Early-, Mid-, and Advanced-Career Mohs Surgeons.
Alhaddad M; Zade J; Nabatian A; Kriegel D; Khorasani H
Dermatol Surg; 2017 Nov; 43(11):1358-1362. PubMed ID: 28538031
[TBL] [Abstract][Full Text] [Related]
15. Benzodiazepine Utilization in Medicare Beneficiaries by Mohs Surgeons and Dermatologists From 2013 to 2017.
Patel P; Guzman AK; Routt E; Ciocon D
Dermatol Surg; 2021 Jun; 47(6):832-834. PubMed ID: 33165056
[No Abstract] [Full Text] [Related]
16. Rapid immunostaining in Mohs: current applications and attitudes.
Trimble JS; Cherpelis BS
Dermatol Surg; 2013 Jan; 39(1 Pt 1):56-63. PubMed ID: 23121199
[TBL] [Abstract][Full Text] [Related]
17. Advances in immunostains used in Mohs surgery.
Stranahan DR; Cherpelis BS; Fenske NA; Glass LF
J Drugs Dermatol; 2010 Jul; 9(7):760-3. PubMed ID: 20677529
[TBL] [Abstract][Full Text] [Related]
18. Skin biopsy and skin cancer treatment use in the Medicare population, 1993 to 2016.
Skaggs R; Coldiron B
J Am Acad Dermatol; 2021 Jan; 84(1):53-59. PubMed ID: 32553682
[TBL] [Abstract][Full Text] [Related]
19. Growing Adoption of Immunohistochemistry by Mohs Micrographic Surgeons: A National Medicare Trend Analysis.
Gronbeck C; Feng H; Knackstedt T
Dermatol Surg; 2024 May; ():. PubMed ID: 38722749
[TBL] [Abstract][Full Text] [Related]
20. Association between number of stages in Mohs micrographic surgery and surgeon-, patient-, and tumor-specific features: a cross-sectional study of practice patterns of 20 early- and mid-career Mohs surgeons.
Alam M; Berg D; Bhatia A; Cohen JL; Hale EK; Herman AR; Huang CC; Jiang SI; Kimyai-Asadi A; Lee KK; Levy R; Rademaker AW; White LE; Yoo SS
Dermatol Surg; 2010 Dec; 36(12):1915-20. PubMed ID: 21040123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
